Research programme: oncolytic virus cancer therapeutics - Microbial Robotics

Drug Profile

Research programme: oncolytic virus cancer therapeutics - Microbial Robotics

Alternative Names: oHSV rQT3 ViruBot

Latest Information Update: 14 Oct 2014

Price : $50

At a glance

  • Originator Bacterial Robotics
  • Developer Microbial Robotics
  • Class Oncolytic viruses
  • Mechanism of Action Tissue inhibitor of metalloproteinase-3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 10 Oct 2014 Bacterial Robotics is now called Microbial Robotics
  • 23 Jun 2014 Preclinical trials in Cancer in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top